The mental faculties a biotech CEO needs most are the first to degrade under chronic pressure. This is not a character issue, ...

Patent attorney Eric M. Brusca, Ph.D., explains how biopharmaceutical companies and their IP law firms can cultivate ...

On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and ...

Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.

Life sciences startups have long felt the gravitational pull of Boston and San Francisco when looking to raise capital, expand, and recruit talent. These two coastal regions, with an established ...

Flourish Research is a fully integrated, multi-site clinical trial network serving sponsors and CROs across North America. We conduct Phase I–IV studies in cardiovascular, metabolic, and oncology, and ...

On this week's episode of the Business of Biotech we speak with Monika Sumra, Ph.D., about how leadership, culture, and performance emerge from the environment and conditions inside an organization.

In biotech, partnerships are often viewed as milestones - announcements that validate a technology or provide funding for the next stage of development. For platform companies, however, collaborations ...

In vitro transcription remains a central yet costly step in RNA manufacturing, particularly for applications like mRNA vaccines. Traditional batch IVT reactions often stall when certain components ...

Clinical trials rely on timely patient enrollment, yet up to 85% of studies fail to recruit or retain enough participants, leading to costly delays and missed market opportunities. To overcome this, ...

Predicting how cells behave in a bioreactor is one of the more demanding challenges in biologics manufacturing. Classical data-driven models offer a practical starting point, but they rely on fitting ...